KRAS and BRAF Mutation Status in Patients with Sporadic Colorectal Cancer: Data from Two Different Mediterranean Countries

Bennani B , Gilles S , Fina F , Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer. Int J Biol Markers 2010; 25: 179–84.

Symvoulakis EK , Zaravinos A , Panutsopulos D , Highly conserved sequence of exon 15 BRAF gene and KRAS codon 12 mutation among Greek patients with colorectal cancer. Int J Biol Markers 2007; 22: 12–8.

Saridaki Z , Tzardi M , Papadaki C , Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥2 line cetuximab-based therapy of colorectal cancer patients. PLoS One 2011; 6: e15980.

Karapetis CS , Khambata-Ford S , Jonker DJ , K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 2008; 359: 1757–65.

Samowitz WS , Curtin K , Schaffer D , Relationship of Ki-ras mutations in colon cancers to tumor location, stage and survival: a population-based study. Cancer Epidemiol Biomarkers Prev 2000; 9: 1193–7.

Lionis C , Symvoulakis EK , Vardavas CI . Implementing family practice research in countries with limited resources: a stepwise model experienced in Crete, Greece. Fam Pract 2010; 27: 48–54.